Summary

The presentation will explore the challenges driving the consolidation of generic medicine supply and the opportunities created by new EU legislation to shift the focus from cost savings to access and security of supply. It will cover the New Pharmaceutical Legislation, the Critical Medicines Act, and broader health security considerations.

Speaker

Adrian van den Hoven has served as Director General of Medicines for Europe since September 2013. He leads the organisation’s work to advance a competitive and resilient off-patent medicines sector, strengthen patient access, reduce shortages, and support Europe’s response to major health challenges. He also helps shape sustainable pricing policies, efficient regulatory frameworks, and a coherent EU industrial strategy to secure the long-term future of the generic, biosimilar, and value-added medicines industries. In addition, he serves on the board of the European Medicines Verification Organization (EMVO), the International Generic and Biosimilar Medicines Association (IGBA), and sits on the industry council of the Health Emergency and Response Authority (HERA).

Atrium Pulse
Is our webinar series made to inspire and connect life science professionals with the experts shaping the industry’s future.
Every two weeks, we pair 15 minutes of sharp insight from a leading voice in the field with 15 minutes of live Q&A - free, online, and open to everyone curious about where life science is heading.

Key words

• Generic medicines
• Pharmaceutical supply chains
• Drug manufacturing
• Supply security
• Healthcare sustainability